Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
90.48B | 87.11B | 81.06B | 77.63B | 75.53B | Gross Profit |
15.48B | 14.92B | 13.36B | 12.14B | 10.46B | EBIT |
3.08B | 3.16B | 2.69B | 1.94B | 465.65M | EBITDA |
3.76B | 4.17B | 3.57B | 2.96B | 1.46B | Net Income Common Stockholders |
1.95B | 1.85B | 1.72B | 1.32B | 204.17M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
18.93B | 18.44B | 16.96B | 15.10B | 12.65B | Total Assets |
37.41B | 35.94B | 33.41B | 31.76B | 30.15B | Total Debt |
13.06M | 17.44M | 12.43M | 15.41M | 18.64M | Net Debt |
-18.91B | -18.43B | -16.94B | -15.09B | -12.63B | Total Liabilities |
8.32B | 8.43B | 7.49B | 7.31B | 6.93B | Stockholders Equity |
29.08B | 27.51B | 25.91B | 24.45B | 23.22B |
Cash Flow | Free Cash Flow | |||
864.34M | 1.94B | 1.93B | 2.41B | 300.61M | Operating Cash Flow |
2.92B | 3.15B | 2.58B | 3.19B | 966.68M | Investing Cash Flow |
-2.07B | -1.26B | -504.48M | -594.71M | -761.04M | Financing Cash Flow |
-372.42M | -401.07M | -225.69M | -148.88M | -341.89M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥36.64B | 10.36 | 2.72% | 11.22% | 49.40% | ||
77 Outperform | ¥31.63B | 16.24 | 1.16% | 3.87% | 5.01% | ||
75 Outperform | ¥28.74B | 7.97 | 2.15% | 3.36% | 30.33% | ||
74 Outperform | ¥33.68B | 14.29 | 2.76% | 10.57% | 4.52% | ||
65 Neutral | $8.73B | 15.10 | 4.69% | 4.08% | 3.64% | -2.90% | |
64 Neutral | ¥30.21B | 12.28 | 1.85% | 1.56% | 40.56% | ||
61 Neutral | ¥33.44B | 23.32 | 1.50% | 10.43% | -0.65% |